Prostate cancer Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Localised prostate cancer staged with conventional imaging who chose to be treated with radical prostatectomy
Exclusion criteria
Exclusion criteria: 1. Patients with clinical stage T4 2. Neoadjuvant hormonotherapy 3. Previous history of radiation therapy 4. Endoscopic or open surgeries of the prostate 5. Urethral stricture 6. Urinary incontinence 7. Neurologic disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery of continence after prostatectomy measured using Expanded Prostate cancer Index Composite (EPIC-26) questionnaire sent at 1, 3, 6 and 12 months post-operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at 1, 3, 6 and 12 months post-operatively: 1. Long term continence measured using Expanded Prostate cancer Index Composite (EPIC-26) questionnaire 2. Erectile function measured using Erectile Function (IIEF-5) 3. Severity of SUI measured using 24-hour pad test at 3, 6 and 12 months | — |
Countries
Canada